LASER FiLaC™ (FISTULA LASER CLOSURE) : First-line Treatment of Complex Anal Fistulas
Launched by FONDATION HÔPITAL SAINT-JOSEPH · Jan 20, 2022
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
A first retrospective study was conducted in the medical and surgical proctology department of the Hospital Group Paris Saint-Joseph on a cohort on 69 consecutive patients seen between May 2016 ans April 2017 and treated by FiLaC™ for a complex anal fistula. This technique has thus cured 60% of patients with superior trans-sphincter fistula. No incontinence-type complications were observed. These results, all the interesting as it was a learning phase, led the investigators to continue to use FiLaC™, which is currently practiced by all the team's practitioners as a first-line sphincter savi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with complex anal fistula treated by the FiLaC™ between 05/01/17 and 05/01/18
- Exclusion Criteria:
- • Patient scheduled for treatment by FiLaC™ and collected as such but finally treated by fistulotomy given a fistula pathway considered intraoperatively less complex than expected
- • Patient with recto vaginal or vaginal skin fistula
- • Patient under guardianship or curators
- • Patient deprived of liberty
- • Patient objecting to the use of their data for this research
About Fondation Hôpital Saint Joseph
Fondation Hôpital Saint-Joseph is a dedicated clinical trial sponsor committed to advancing healthcare and improving patient outcomes through innovative research. Located in a reputable healthcare institution, the foundation collaborates with healthcare professionals and researchers to conduct high-quality clinical trials across various medical fields. By fostering a culture of scientific excellence and patient-centered care, Fondation Hôpital Saint-Joseph aims to contribute valuable insights to the medical community and enhance the quality of treatments available to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Ile De France, France
Patients applied
Trial Officials
Vincent De PARADES, M.D
Principal Investigator
Fondation Hôpital Saint-Joseph
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials